Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03397693|
Recruitment Status : Recruiting
First Posted : January 12, 2018
Last Update Posted : January 12, 2018
|Condition or disease|
|Unexplained Infertility PCOS Endometrial Thickness|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||185 participants|
|Official Title:||Assessment of Endometrial Thickness & Subendometrial Perfusion by 3D Power Doppler in Women With Unexplained Infertility and PCOS.|
|Estimated Study Start Date :||January 2018|
|Estimated Primary Completion Date :||December 2018|
|Estimated Study Completion Date :||March 2019|
Women with unexplained infertiltiy with no treatment given
Women with Poly Cystic Ovary Syndrome (PCOS) who are being treated with different drugs of ovulation induction.
Control fertile women with no treatment given.
- Endometrial thickness and 3d Power Doppler indices of subendometrium [ Time Frame: Mid luteal phase defined as (Day 20-23) of the menstrual cycle for each patient ]Thickest part of the endometrium in sagittal plane by transvaginal ultrasound
- Clinical pregnancy [ Time Frame: After 6 weeks from last menstrual period and positive pregnancy test ]Visualization of one or more gestational sacs by transvaginal ultrasound
- 2D Doppler indices of both uterine arteries [ Time Frame: Mid luteal phase defined as (Day 20-23) of the menstrual cycle for each patient ]S/D, RI, PI of uterine arteries.
- Endometrial volume [ Time Frame: Mid luteal phase defined as (Day 20-23) of the menstrual cycle for each patient ]Using VOCAL software during transvaginal ultrasound examination
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03397693
|Department of Obstetrics and Gynecology, School of Medicine, Assiut University||Recruiting|
|Assiut, Egypt, 71500|
|Contact: Moustafa Gadalla, Assistant lecturer +201029711066 email@example.com|
|Principal Investigator: Moustafa Gadalla, Assistant lecturer|
|Principal Investigator: Ali Elsaman, Professor|
|Principal Investigator: Sayed Abdulhameid, Professor|
|Principal Investigator: Alaa Ismail, Professor|